유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

immunomedics gmbh - sulesomab - osteomyelitis; radionuclide imaging - diagnostilised ained - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. leukoscan on näidustatud diagnostiliste määramise asukoht ja ulatus nakkus/põletik luu patsientidel, kellel kahtlustatakse osteomüeliit, sealhulgas patsientidel, kellel on diabeetiline suu haavandid. leukoscan ei ole hõivatud, et diagnoosida osteomüeliit patsientidel, kellel on sirprakuline aneemia.

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

lipomed gmbh - cladribine - leukeemia, karvane rakk - antineoplastilised ained - litak on näidustatud karvrakulise leukeemia raviks.

에스토니아 - 에스토니아어 - Ravimiamet

vetviva richter gmbh - pentobarbitaal - süstelahus - 364,6mg 1ml 100ml 5tk

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

sandoz gmbh - natalisumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosupressandid - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 ja 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

elanco gmbh - tulatromütsiin - antibakteriaalsed ained süsteemseks kasutamiseks - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. haiguse esinemine karjas tuleb kindlaks määrata enne metafülaktilist ravi. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. haiguse esinemine karjas tuleb kindlaks määrata enne metafülaktilist ravi. the product should only be used if pigs are expected to develop the disease within 2–3 days. lambad: nakkusliku pododermatiidi (suu mädanemine) varajase staadiumi ravi, mis on seotud virulentse dichelobacter nodosus'ega ja vajab süsteemset ravi.

에스토니아 - 에스토니아어 - Ravimiamet

vetviva richter gmbh - buprenorfiin - süstelahus - 0,3mg 1ml 10ml 10tk; 0,3mg 1ml 10ml 1tk; 0,3mg 1ml 10ml 5tk

에스토니아 - 에스토니아어 - Ravimiamet

g.l. pharma gmbh - simetikoon - suukaudne suspensioon - 41,2mg 1ml 50ml 1tk; 41,2mg 1ml 100ml 1tk

에스토니아 - 에스토니아어 - Ravimiamet

vetviva richter gmbh - buprenorfiin - süstelahus - 0,3mg 1ml 2ml 10tk; 0,3mg 1ml 2ml 3tk; 0,3mg 1ml 2ml 6tk; 0,3mg 1ml 2ml 4tk; 0,3mg 1ml 2ml 5tk

에스토니아 - 에스토니아어 - Ravimiamet

sandoz gmbh - batsitratsiin+neomütsiin - salv - 250rÜ+5000rÜ 1g 20g 1tk

에스토니아 - 에스토니아어 - Ravimiamet

vetviva richter gmbh - lidokaiin - süstelahus - 20mg 1ml 50ml 5tk; 20mg 1ml 50ml 1tk; 20mg 1ml 100ml 1tk